The charcot foot in diabetes

Journal of the American Podiatric Medical Association

Volumn 101, Issue 5, 2011, Pages 437-446

  Rogers, Lee C ^a   Frykberg, Robert G ^b   Armstrong, David G ^c   Boulton, Andrew J M ^d   Edmonds, Michael ^e   Van, Georges Ha ^f   Hartemann, Agnes ^f   Game, Frances ^g   Jeffcoate, William ^g   Jirkovska, Alexandra ^h   Jude, Edward ^d   Morbach, Stephan ⁱ   Morrison, William B ^j   Pinzur, Michael ^k   Pitocco, Dario ^l   Sanders, Lee ^m   Wukich, Dane K ⁿ   Uccioli, Luigi ^o  

^a Valley Presbyterian Hospital   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^h INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

ⁱ Department of Diabetes and Angiology ^*  (Germany)

^j THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^k LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^l CATHOLIC UNIVERSITY   (Italy)

^m VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^o UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053233942     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/1010437     Document Type: Article

References (82)

1. Jeffcoate WJ, Game F, Cavanagh PR: The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 366: 2058, 2005.
2. Boyce BF, Xing L: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473: 139, 2008.
3. Uccioli L, Sinistro A, Almerighi C, et al: Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care 33: 350, 2010.
4. Mabilleau G, Petrova NL, Edmonds ME, et al: Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factorkappaB ligand. Diabetologia 51: 1035, 2008.
5. Stevens MJ, Edmonds ME, Foster AV, et al: Selective neuropathy and preserved vascular responses in the diabetic Charcot foot. Diabetologia 35: 148, 1992.
6. Young MJ, Marshall A, Adams JE, et al: Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 18: 34, 1995.
7. Veves A, Akbari CM, Primavera J, et al: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 47: 457, 1998.
8. Shapiro SA, Stansberry KB, Hill MA, et al: Normal blood flow response and vasomotion in the diabetic Charcot foot. J Diabetes Complications 12: 147, 1998.
9. Baker N, Green A, Krishnan S, et al: Microvascular and C-fiber function in diabetic Charcot neuroarthropathy and diabetic peripheral neuropathy. Diabetes Care 30: 3077, 2007.
10. Jeffcoate WJ, Game FL: "New Theories on the Causes of the Charcot Foot in Diabetes, " in The Diabetic Charcot Foot: Principles and Management ed by RG Frykberg, p 29, Data Trace Publishing Company, Brooklandville, MD, 2010.
11. Herbst SA, Jones KB, Saltzman CL: Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 86: 378, 2004.
12. Hofbauer LC, Brueck CC, Singh SK, et al: Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22: 1317, 2007.
13. Matricali GA, Bammens B, Kuypers D, et al: High rate of Charcot foot attacks early after simultaneous pancreaskidney transplantation. Transplantation 83: 245, 2007.
14. Pitocco D, Zelano G, Gioffrè G, et al: Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a casecontrol study. Diabetes Care 32: 1694, 2009.
15. Foltz KD, Fallat LM, Schwartz S: Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. J Foot Ankle Surg 43: 87, 2004.
16. Eichenholtz SN: Charcot Joints, Charles C. Thomas, Springfield, IL, 1966.
17. Charcot J-M, Fere C: Affections osseuses et articulaires du pied chez les tabétiques (Pied tabétique) [in French]. Archives de Neurologie 6: 305, 1883.
18. Cofield RH, Morrison MJ, Beabout JW, et al: Diabetic neuroarthropathy in the foot: patient characteristics and patterns of radiographic change. Foot Ankle 4: 15, 1983.
19. Johnson JT: Neuropathic fractures and joint injuries. Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am 49: 1, 1967.
20. Armstrong DG, Todd WF, Lavery LA, et al: The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 14: 357, 1997.
21. Henderson VE: Joint affections in tabes dorsalis. J Pathol 10: 211, 1905.
22. Caputo GM, Ulbrecht J, Cavanagh PR, et al: The Charcot foot in diabetes: six key points. Am Fam Physician 57: 2705, 1998.
23. Jeffcoate W: The causes of the Charcot syndrome. Clin Podiatr Med Surg 25: 29, 2008.
24. McGill M, Molyneaux L, Bolton T, et al: Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques. Diabetologia 43: 481, 2000.
25. Sinha S, Munichoodappa CS, Kozak GP: Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 51: 191, 1972.
26. Sanders LJ, Frykberg RG: "The Charcot Foot (Pied de Charcot), " in Levin and O'Neal's The Diabetic Foot, 7th Ed, ed by JH Bowker, MA Pfeifer, p 257, Mosby Elsevier, Philadelphia, 2007.
27. Morrison WB, Shortt CP, Ting AYI: "Imaging of the Charcot foot, " in The Diabetic Charcot Foot: Principles and Management ed by RG Frykberg, p 65, Data Trace Publishing Company, Brooklandville, MD, 2010.
28. Morrison WB, Ledermann HP: Work-up of the diabetic foot. Radiol Clin North Am 40: 1171, 2002.
29. Morrison WB, Ledermann HP, Schweitzer ME: MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am 9: 603, 2001.
30. Larcos G, Brown ML, Sutton RT: Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111Inleukocyte scintigraphy. AJR Am J Roentgenol 157: 527, 1991.
31. Palestro CJ, Mehta HH, Patel M, et al: Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 39: 346, 1998.
32. Keidar Z, Militianu D, Melamed E, et al: The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med 46: 444, 2005.
33. Hopfner S, Krolak C, Kessler S, et al: Preoperative imaging of Charcot neuroarthropathy. Does the additional application of 18F-FDG-PET make sense? Nuklearmedizin 45: 15, 2005.
34. Frykberg RG, Eneroth M: "Principles of conservative management, " in The Diabetic Charcot Foot: Principles and Management ed by RG Frykberg, p 93, Data Trace Publishing Company, Brooklandville, MD, 2010.
35. Armstrong DG, Lavery LA: Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev 34: 317, 1997.
36. Armstrong DG, Lavery LA, Wu S, et al: Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 28: 551, 2005.
37. Armstrong DG, Short B, Espensen EH, et al: Technique for fabrication of an "instant total-contact cast" for treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc 92: 405, 2002.
38. Selby PL, Young MJ, Boulton AJ: Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy? Diabet Med 11: 28, 1994.
39. Jude EB, Selby PL, Burgess J, et al: Bisphosphonates in the treatment of Charcot neuroarthropathy: a doubleblind randomised controlled trial. Diabetologia 44: 2032, 2001.
40. Pitocco D, Ruotolo V, Caputo S, et al: Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care 28: 1214, 2005.
41. Anderson JJ, Woelffer KE, Holtzman JJ, et al: Bisphosphonates for the treatment of Charcot neuroarthropathy. J Foot Ankle Surg 43: 285, 2004.
42. Hofbauer LC, Hamann C, Ebeling PR: Approach to the patient with secondary osteoporosis. Eur J Endocrinol 162: 1009, 2010.
43. Bem R, Jirkovská A, Fejfarová V, et al: Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 29: 1392, 2006.
44. Molines L, Darmon P, Raccah D: Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 36: 251, 2010.
45. Ulbrecht JS, Wukich DK: The Charcot foot: medical and surgical therapy. Curr Diab Rep 8: 444, 2008.
46. Wukich DK, Sung W: Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications 23: 409, 2009.
47. Strauss E, Gonya G: Adjunct low intensity ultrasound in Charcot neuroarthropathy. Clin Orthop Relat Res 349: 132, 1998.
48. Hockenbury RT, Gruttadauria M, McKinney I: Use of implantable bone growth stimulation in Charcot ankle arthrodesis. Foot Ankle Int 28: 971, 2007.
49. Petrisor B, Lau JT: Electrical bone stimulation: an overview and its use in high risk and Charcot foot and ankle reconstructions. Foot Ankle Clin 10: 609, 2005.
50. Pinzur MS: "Surgical Management: History and General Principles, " in The Diabetic Charcot Foot: Principles and Management, ed by RG Frykberg, p 165, Data Trace Publishing Company, Brooklandville, MD, 2010.
51. Dhawan V, Spratt KF, Pinzur MS, et al: Reliability of AOFAS diabetic foot questionnaire in Charcot arthropathy: stability, internal consistency, and measurable difference. Foot Ankle Int 26: 717, 2005.
52. Lavery LA, Armstrong DG, Boulton AJ, et al: Ankle equinus deformity and its relationship to high plantar pressure in a large population with diabetes mellitus. JAPMA 92: 479, 2002.
53. Armstrong DG, Lavery LA: Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 80: 365, 1998.
54. Hastings MK, Mueller MJ, Sinacore DR, et al: Effects of a tendo-Achilles lengthening procedure on muscle function and gait characteristics in a patient with diabetes mellitus. J Orthop Sports Phys Ther 30: 85, 2000.
55. Maluf KS, Mueller MJ, Strube MJ, et al: Tendon Achilles lengthening for the treatment of neuropathic ulcers causes a temporary reduction in forefoot pressure associated with changes in plantar flexor power rather than ankle motion during gait. J Biomech 37: 897, 2004.
56. Holstein P, Lohmann M, Bitsch M, et al: Achilles tendon lengthening, the panacea for plantar forefoot ulceration? Diabetes Metab Res Rev 20 (Suppl 1): S37, 2004.
57. Mueller MJ, Sinacore DR, Hastings MK, et al: Impact of Achilles tendon lengthening on functional limitations and perceived disability in people with a neuropathic plantar ulcer. Diabetes Care 27: 1559, 2004.
58. Catanzariti AR, Mendicino R, Haverstock B: Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg 39: 291, 2000.
59. Rosenblum BI, Giurini JM, Miller LB, et al: Neuropathic ulcerations plantar to the lateral column in patients with Charcot foot deformity: a flexible approach to limb salvage. J Foot Ankle Surg 36: 360, 1997.
60. Laurinaviciene R, Kirketerp-Moeller K, Holstein PE: Exostectomy for chronic midfoot plantar ulcer in Charcot deformity. J Wound Care 17: 53, 2008.
61. Mittlmeier T, Klaue K, Haar P, et al: Should one consider primary surgical reconstruction in Charcot arthropathy of the feet? Clin Orthop Relat Res 468: 1002, 2010.
62. Simon SR, Tejwani SG, Wilson DL, et al: Arthrodesis as an early alternative to nonoperative management of Charcot arthropathy of the diabetic foot. J Bone Joint Surg Am 82-A: 939, 2000.
63. Papa J, Myerson M, Girard P: Salvage, with arthrodesis, in intractable diabetic neuropathic arthropathy of the foot and ankle. J Bone Joint Surg Am 75: 1056, 1993.
64. Pakarinen TK, Laine HJ, Honkonen SE, et al: Charcot arthropathy of the diabetic foot. Current concepts and review of 36 cases. Scand J Surg 91: 195, 2002.
65. Stone NC, Daniels TR: Midfoot and hindfoot arthrodeses in diabetic Charcot arthropathy. Can J Surg 43: 449, 2000.
66. Pinzur M: Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int 25: 545, 2004.
67. Garapati R, Weinfeld SB: Complex reconstruction of the diabetic foot and ankle. Am J Surg 187 (5A): 81S, 2004.
68. Assal M, Stern R: Realignment and extended fusion with use of a medial column screw for midfoot deformities secondary to diabetic neuropathy. J Bone Joint Surg Am 91: 812, 2009.
69. Pinzur MS: Neutral ring fixation for high-risk nonplantigrade Charcot midfoot deformity. Foot Ankle Int 28: 961. 2007.
70. Farber DC, Juliano PJ, Cavanagh PR, et al: Single stage correction with external fixation of the ulcerated foot in individuals with Charcot neuroarthropathy. Foot Ankle Int 23: 130, 2002.
71. Fabrin J, Larsen K, Holstein PE: Arthrodesis with external fixation in the unstable or misaligned Charcot ankle in patients with diabetes mellitus. Int J Low Extrem Wounds 6: 102, 2007.
72. Wukich DK, Belczyk RJ, Burns PR: Complications encountered with circular ring fixation in persons with diabetes mellitus. Foot Ankle Int 29: 994, 2008.
73. Bevilacqua NJ, Rogers LC: Surgical management of Charcot midfoot deformities. Clin Podiatr Med Surg 25: 81, 2008.
74. Rogers LC, Bevilacqua NJ, Frykberg RG, et al: Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle. J Foot Ankle Surg 46: 372, 2007.
75. Connolly JF, Csencsitz TA: Limb threatening neuropathic complications from ankle fractures in patients with diabetes. Clin Orthop Relat Res 348: 212, 1998.
76. Jani MM, Ricci WM, Borrelli J Jr, et al: A protocol for treatment of unstable ankle fractures using transarticular fixation in patients with diabetes mellitus and loss of protective sensibility. Foot Ankle Int 24: 838, 2003.
77. Perry MD, Taranow WS, Manoli A 2nd, et al: Salvage of failed neuropathic ankle fractures: use of large-fragment fibular plating and multiple syndesmotic screws. J Surg Orthop Adv 14: 85, 2005.
78. Wukich DK, Joseph A, Ryan M, et al: Outcomes of ankle fractures in patients with uncomplicated versus complicated diabetes. Foot Ankle Int 32: 120, 2011.
79. Ayoub MA: Ankle fractures in diabetic neuropathic arthropathy: can tibiotalar arthrodesis salvage the limb? J Bone Joint Surg Br 90: 906, 2008.
80. Dalla Paola L, Volpe A, Varotto D, et al: Use of a retrograde nail for ankle arthrodesis in Charcot neuroarthropathy: a limb salvage procedure. Foot Ankle Int 28: 967, 2007.
81. Caravaggi C, Cimmino M, Caruso S, et al: Intramedullary compressive nail fixation for the treatment of severe Charcot deformity of the ankle and rear foot. J Foot Ankle Surg 45: 20, 2006.
82. Pinzur MS, Noonan T: Ankle arthrodesis with a retrograde femoral nail for Charcot ankle arthropathy. Foot Ankle Int 26: 545, 2005.